The latest announcement is out from Tong Ren Tang Technologies Co ( (HK:1666) ).
Tong Ren Tang Technologies Co. Ltd. announced its unaudited financial results for the first quarter of 2025, reporting an operating revenue of approximately RMB2,035.42 million and a net profit of RMB227.23 million. The announcement highlights the company’s financial stability and growth potential, reinforcing its strong position in the traditional Chinese medicine industry.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. operates in the pharmaceutical industry, focusing on traditional Chinese medicine products and healthcare services. The company is a key player in the market, leveraging its heritage and expertise in herbal medicine to cater to both domestic and international markets.
YTD Price Performance: -5.38%
Average Trading Volume: 800
Technical Sentiment Signal: Buy
Current Market Cap: $789.2M
For an in-depth examination of 1666 stock, go to TipRanks’ Stock Analysis page.